To find the clinical relevance of our data that RORα2 and LSD1 protein levels are remarkably increased in breast cancer cell lines, we analyzed the protein levels of RORα2 and LSD1 in human breast cancer specimens along with normal counterparts. The gene discussed is KDM1A; the disease is breast carcinoma.